• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

C1 inhibitors opening doors

C1-INH treatment shortened the mean duration of abdominal attacksfrom 92 to 40 hours and the mean maximal pain score declined from8.6 to 4.5.

Related Videos
Related Content
Psychosocial Impact of Alopecia Areata on Pediatric and Adolescent Patients
October 9th 2024

Psychosocial Impact of Alopecia Areata on Pediatric and Adolescent Patients

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 1st 2023

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors
September 10th 2024

Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors

The Cutaneous Connection
August 5th 2021

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

Case of Juvenile Bullous Pemphigoid with Negative Serum BP180 ELISA Test Reveals Need for Additional Testing
August 27th 2024

Case of Juvenile Bullous Pemphigoid with Negative Serum BP180 ELISA Test Reveals Need for Additional Testing

DPCP Immunotherapy Yields 61.8% Hair Regrowth Rate in Pediatric Alopecia Areata
August 27th 2024

DPCP Immunotherapy Yields 61.8% Hair Regrowth Rate in Pediatric Alopecia Areata

© 2024 MJH Life Sciences

All rights reserved.